# Hubei University of Chinese Medicine

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/hubei-university-of-chinese-medicine/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 68.5 |
| Citations | 284,569 |
| City | Wuhan |
| Country | CN |
| Description | Hubei University of Chinese Medicine is a research organisation in Wuhan, CN. OpenAlex records 8,091 works and 284,569 citations for it. 4,145 researchers list it as their most recent affiliation. |
| Homepage | http://www.hbtcm.edu.cn/2014xinban/ |
| OpenAlex ID | https://openalex.org/I205016115 |
| Researchers | 4,145 |
| ROR ID | https://ror.org/02my3bx32 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q5927051 |
| Works | 8,091 |

## University papers

- [Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis](https://scholariq.org/papers/comparison-of-laboratory-tests-ultrasound-or-magnetic-resonance-elastography-to/)
- [First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study](https://scholariq.org/papers/first-line-erlotinib-versus-gemcitabine-cisplatin-in-patients-with-advanced-egfr/)
- [A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma](https://scholariq.org/papers/a-prospective-randomized-study-comparing-outcomes-and-toxicities-of-intensity/)
- [Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study](https://scholariq.org/papers/clinical-characteristics-outcomes-and-risk-factors-for-mortality-in-patients/)
- [Household transmission of SARS-CoV-2](https://scholariq.org/papers/household-transmission-of-sars-cov-2/)
- [Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer](https://scholariq.org/papers/ensartinib-vs-crizotinib-for-patients-with-anaplastic-lymphoma-kinase-positive/)
- [Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study](https://scholariq.org/papers/molecular-epidemiology-of-egfr-mutations-in-asian-patients-with-advanced-non/)
- [Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial](https://scholariq.org/papers/icotinib-versus-whole-brain-irradiation-in-patients-with-egfr-mutant-non-small/)
- [Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer](https://scholariq.org/papers/phase-ii-single-arm-trial-of-preoperative-short-course-radiotherapy-followed-by/)
- [Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial](https://scholariq.org/papers/prognostic-value-of-end-of-induction-pet-response-after-first-line/)
- [Rebiopsy in patients with or without prior TKIs revealed complicated histology of lung cancer.](https://scholariq.org/papers/rebiopsy-in-patients-with-or-without-prior-tkis-revealed-complicated-histology/)

## University researchers

- [Gang Wu](https://scholariq.org/researchers/gang-wu/)

## University top topics

Showing 8 of 25.

- [Traditional Chinese Medicine Studies](https://scholariq.org/topics/traditional-chinese-medicine-studies/)
- [Traditional Chinese Medicine Analysis](https://scholariq.org/topics/traditional-chinese-medicine-analysis/)
- [Acupuncture Treatment Research Studies](https://scholariq.org/topics/acupuncture-treatment-research-studies/)
- [Pharmacological Effects of Natural Compounds](https://scholariq.org/topics/pharmacological-effects-of-natural-compounds/)
- [Healthcare and Venom Research](https://scholariq.org/topics/healthcare-and-venom-research/)
- [Natural product bioactivities and synthesis](https://scholariq.org/topics/natural-product-bioactivities-and-synthesis/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Medicinal Plant Pharmacodynamics Research](https://scholariq.org/topics/medicinal-plant-pharmacodynamics-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.